The Feasibility and Reliability of Utilizing Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Qualitative Interpretation of Amyvid Brain Scans

Trial Profile

The Feasibility and Reliability of Utilizing Commercially Available Quantitative Analysis Software as an Adjunct to the Clinical Qualitative Interpretation of Amyvid Brain Scans

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Jul 2015

At a glance

  • Drugs Florbetapir F 18 (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 18 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top